# VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients

> **NCT01130181** · PHASE3 · COMPLETED · sponsor: **Harald Dobnig, MD** · enrollment: 480 (actual)

## Conditions studied

- Critical Illness
- Vitamin D Deficiency

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01130181
- **Lead sponsor:** Harald Dobnig, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 480 (ACTUAL)
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130181, "VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01130181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*